HeartSciences (HSCS) Research & Development (2021 - 2026)
HeartSciences (HSCS) reported Research & Development of $638575.0 for Q1 2026, down 38.19% on a YoY basis from $1.0 million in Q1 2025, and down 12.17% quarter-over-quarter from $727026.0 in Q4 2025.
HeartSciences (HSCS) Research & Development (2021 - 2026) Analysis & Trends
HeartSciences has reported Research & Development for 6 years, with the latest figure at $638575.0 in Q1 2026.
- For the quarter ending Q1 2026, Research & Development fell 38.19% year-over-year to $638575.0; the trailing twelve-month figure through Jan 2026 stood at $3.3 million (down 26.9% YoY), and the FY2025 full-year result was $4.4 million, up 52.37% from the prior year.
- Research & Development for Q1 2026 stood at $638575.0, down from $727026.0 in the prior quarter.
- The five-year high for Research & Development was $1.4 million in Q2 2022, with the low at $434198.0 in Q3 2022.
- Historically, Research & Development has averaged $831939.9 across 5 years, with a median of $757303.0 in 2023.
- Annual changes were most pronounced in 2023 — Research & Development slumped 60.58% — and 2024, when it surged 116.56%.
- HeartSciences' Research & Development stood at $848976.0 in 2022, then declined by 10.8% to $757303.0 in 2023, then soared by 58.32% to $1.2 million in 2024, then plunged by 39.36% to $727026.0 in 2025, then dropped by 12.17% to $638575.0 in 2026.
- The last three Research & Development figures came in at $638575.0 (Q1 2026), $727026.0 (Q4 2025), and $997206.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 722.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -461.27 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 145.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 28.80 Mn |
| 10 | HeartSciences | 3.89 Mn | 492,884.20 | - | 638,575.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 638,575.00 |
| Oct 31, 2025 | 727,026.00 |
| Jul 31, 2025 | 997,206.00 |
| Apr 30, 2025 | 929,091.00 |
| Jan 31, 2025 | 1.03 Mn |
| Oct 31, 2024 | 1.20 Mn |
| Jul 31, 2024 | 1.22 Mn |
| Apr 30, 2024 | 1.05 Mn |
| Jan 31, 2024 | 509,507.00 |
| Oct 31, 2023 | 757,303.00 |
| Jul 31, 2023 | 565,632.00 |
| Apr 30, 2023 | 534,436.00 |
| Jan 31, 2023 | 643,258.00 |
| Oct 31, 2022 | 848,976.00 |
| Jul 31, 2022 | 434,198.00 |
| Apr 30, 2022 | 1.36 Mn |
| Jan 31, 2022 | 699,015.00 |
| Oct 31, 2021 | 545,773.00 |
| Jul 31, 2021 | 401,114.00 |